Arkolith/Insider Trading/AUGX/Form 4

Ginocchio Paul

CHIEF FINANCIAL OFFICERAugmedix, Inc. (AUGX) · full profile →Form 4 · filed Oct 4, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
1 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 2, 2024Disposed to issuer(D)136K$2.35$319K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 2, 2024Disposed to issuer(D)60K—$00
Oct 2, 2024Disposed to issuer(D)112K—$00
Oct 2, 2024Disposed to issuer(D)125K—$00
Oct 2, 2024Disposed to issuer(D)233K—$00
Oct 2, 2024Disposed to issuer(D)88K—$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-085356) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML